2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$4.11+$0.04 (+1.01%)
Price as of Oct 02, 2026 5:50 PM EDT- $2.2BMarket Cap
- -26.27%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$4.11+$0.04 (+1.01%)
Earnings Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -9.26% | ||
12-Month Momentum | -34.71% | ||
3-Month Risk Adjusted Momentum | -32.64% | ||
12-Month Risk Adjusted Momentum | -49.53% |
True Yield
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.01% | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |